19-16893308-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015692.5(CPAMD8):āc.5458A>Gā(p.Ser1820Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000776 in 1,546,952 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015692.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CPAMD8 | NM_015692.5 | c.5458A>G | p.Ser1820Gly | missense_variant | 42/42 | ENST00000443236.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CPAMD8 | ENST00000443236.7 | c.5458A>G | p.Ser1820Gly | missense_variant | 42/42 | 1 | NM_015692.5 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152250Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000623 AC: 1AN: 160396Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 85820
GnomAD4 exome AF: 0.00000359 AC: 5AN: 1394584Hom.: 0 Cov.: 31 AF XY: 0.00000146 AC XY: 1AN XY: 686750
GnomAD4 genome AF: 0.0000459 AC: 7AN: 152368Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74508
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 01, 2022 | The c.5599A>G (p.S1867G) alteration is located in exon 42 (coding exon 42) of the CPAMD8 gene. This alteration results from a A to G substitution at nucleotide position 5599, causing the serine (S) at amino acid position 1867 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at